Skip to main content
logo
BridgeBio Pharma, Inc. (FRA:2CL)
Germany flag Germany · Delayed Price · Currency is EUR
63.00
-0.50 (-0.79%)
Last updated: Jan 8, 2026, 8:55 AM CET

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Transformative Medicines
221.90M
Log In
Log In
Log In
Log In
Upgrade
Transformative Medicines Growth
2285.27%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
EMEA
132.03M
Log In
Log In
Log In
Log In
Upgrade
APAC
76.56M
Log In
Log In
Log In
Log In
Upgrade
North America
13.31M
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-
Log In
Log In
Log In
Log In
Upgrade
China
-
Log In
Log In
Log In
Log In
Upgrade
China Growth
-
Log In
Log In
Log In
Log In
Upgrade
Foreign
-
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
-
Log In
Log In
Log In
Log In
Upgrade
Switzerland
-
Log In
Log In
Log In
Log In
Upgrade